Companies: 10,795·Total market cap: $144.5T
SpectraScience, Inc.

SpectraScience, Inc.

SCIEOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$4924
P/E Ratio
52W High$0.0001
52W Low$0.000001

SpectraScience, Inc. (SCIE) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

scie · pe ratio · data through Dec 31, 2016

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for SpectraScience, Inc. (SCIE) measures how much investors pay for each dollar of the company's trailing earnings. SCIE's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2016-12-31

Forward P/E
N/A
EPS (TTM)
-$0.01
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SpectraScience, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

1995 – 2016 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Specialties · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
SpectraScience, Inc.
SpectraScience, Inc.You
SCIE
$0MN/A-$0.01
Arno Therapeutics, Inc.
Arno Therapeutics, Inc.
ARNI
$0MN/A-$0.57
Better Therapeutics, Inc.
Better Therapeutics, Inc.
BTTX
$0MN/A-$1.69
Calithera Biosciences, Inc.
Calithera Biosciences, Inc.
CALA
$0MN/A-$3.78
Dermisonics, Inc.
Dermisonics, Inc.
DMSI
$0MN/A-$0.12
IMRIS Inc.
IMRIS Inc.
IMRSQ
$0MN/A-$0.58
Inyx, Inc.
Inyx, Inc.
IYXI
$0MN/A-$0.78

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2016-12-31Latest
FY2016
$-0.01
2015-12-31
FY2015
$-0.02
2014-12-31
FY2014
$-0.03
2013-12-31
FY2013
$-0.02
2012-12-31
FY2012
$-0.08
2011-12-31
FY2011
$-0.04
2010-12-31
FY2010
$-0.04
2009-12-31
FY2009
$-0.06
2008-12-31
FY2008
$-0.08
2007-12-31
FY2007
$-0.07

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for SpectraScience, Inc. (SCIE) measures how much investors pay for each dollar of the company's trailing earnings. SCIE's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.01 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

SCIE pe ratio · 6 questions

SCIE's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via SCIE's SEC 10-K and 10-Q filings.

SCIE PE ratioWhat is SCIE PE ratioCurrent PE ratio of SCIESCIE PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SpectraScience, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08